This compound is a deuterated derivative of a beta-adrenergic agonist intended for veterinary pharmaceutical manufacturing. It features a tricyclic core incorporating heterocyclic and aromatic rings, with isotopic labeling at the isopropylamine side chain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(+)-cis-Diltiazem-d3 HCl (acetoxy-d3)
pharmaceutical raw material
Xylometazoline hydrochloride
pharmaceutical raw material
Pidotimod
pharmaceutical raw material
Carbovir triphosphate
pharmaceutical raw material
Zilpaterol hydrochloride
pharmaceutical raw material
Zilpaterol hydrochloride
pharmaceutical raw material
Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 6-amino-4,5,6,7-tetrahydro-7-hydroxy-
research compound
(9S,10S)-10-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-9-hydroxy-1,3-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-trien-2-one
ZSTCZWJCLIRCOJ-FNKPLXHESA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])N[C@H]1CCN2C3=C([C@@H]1O)C=CC=C3NC2=O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.